Active surveillance of Streptococcus pneumoniae bacteremia in Italian children

L Tarallo1, F Tancredi, G Schito

  • 1PO San Leonardo/ASL NA5, Corso Europa, 80053 Castellammare di Stabia, Napoli, Italy. luigi.tarallo@tin.it

Vaccine
|August 12, 2006
PubMed

Insights

This study found an incidence of 1.2% for Streptococcus pneumoniae bacteremia in Italian children under five. Common serotypes were 14, 23F, and 19F, with many covered by the pneumococcal vaccine.

Area of Science:

  • Pediatric Infectious Diseases
  • Bacteriology
  • Epidemiology

Background:

  • Limited data exist on Streptococcus pneumoniae bacteremia incidence in Italian children.
  • Streptococcus pneumoniae (Sp) is a major cause of childhood bacterial infections globally.
  • Understanding local epidemiology is crucial for effective prevention strategies.

Purpose of the Study:

  • To determine the incidence of Sp bacteremia in Italian children under five years of age.
  • To identify prevalent Sp serotypes causing bacteremia in this age group.
  • To assess the antimicrobial susceptibility of Sp isolates.

Main Methods:

  • A 14-month prospective surveillance study was conducted across 10 pediatric hospitals.
  • Blood cultures were analyzed for Sp identification.
  • Serotype prevalence and antimicrobial susceptibility testing were performed on isolates.

Main Results:

  • An overall incidence rate of 1.2% for Sp bacteremia was observed (55 isolates from 4576 blood cultures).
  • The most frequent serotypes were 14, 23F, 19F, 9V, and 1.
  • Serotypes included in the 7-valent conjugate pneumococcal vaccine accounted for 70% of isolates in children under 2 years and 58% in those aged 2-5 years.

Conclusions:

  • Sp bacteremia incidence in Italian children under five is relatively low but significant.
  • The 7-valent pneumococcal conjugate vaccine covers a substantial proportion of causative serotypes in young children.
  • Continued surveillance is necessary to monitor trends and vaccine effectiveness.